Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Focusing on the clinical value of finerenone, the medical community is conducting in-depth discussions.Does finerenone workThe drug reduces the rate of protein excretion by selecti···【more】
Article source：Captain MedicineRelease date：2025-04-18Recommended：302
The medical community is always exploring new treatment options, and this article focuses on the clinical application and patient management of finerenone.Is finerenone treatment e···【more】
Article source：Captain MedicineRelease date：2025-04-18Recommended：371
Knowing the dosage of a drug is an important basis for rational drug use.What is the dosage of finerenoneFor adult patients, the usual starting dose of finerenone is 10 mg daily.St···【more】
Article source：Captain MedicineRelease date：2025-04-17Recommended：335
The new drug finerenone has attracted widespread attention in the field of chronic disease treatment.How effective is finerenone?Data from the phase III clinical trial showed that ···【more】
Article source：Captain MedicineRelease date：2025-04-17Recommended：281
The rational use of finerenone and patient management should be combined with scientific guidance and individualized needs.How to use finerenoneStandardizing the medication process···【more】
Article source：Captain MedicineRelease date：2025-04-16Recommended：255
Around the rational use of this drug, dosage specifications are the focus of both patients and healthcare workers.What is the recommended dosage of finerenone?The initial dose of f···【more】
Article source：Captain MedicineRelease date：2025-04-16Recommended：327
This article analyzes the clinical application and economic cost of finerenone.What are the suitable populations for finerenone?The use of this drug should be strictly in accordanc···【more】
Article source：Captain MedicineRelease date：2025-04-15Recommended：259
According to the treatment needs of patients with specific chronic diseases, the application value of finerenone has gradually attracted attention.What diseases is finerenone suita···【more】
Article source：Captain MedicineRelease date：2025-04-15Recommended：244
In view of the application value and clinical practice of finerenone, this article reviews the key information.What are the indications for finerenoneThis drug has shown a unique r···【more】
Article source：Captain MedicineRelease date：2025-04-14Recommended：204
Finerenone is an important drug for the treatment of type 2 diabetes-related chronic kidney disease, and its price and influencing factors have always been the focus of patients···【more】
Article source：Captain MedicineRelease date：2025-04-14Recommended：255
The pricing of finerenone will be significantly diverse in 2025 depending on region, version, and health insurance policy differences.Finerenone latest price in 2025The export pric···【more】
Article source：Captain MedicineRelease date：2025-04-11Recommended：244
The price of different versions of finerenone varies significantly, and it needs to be comprehensively evaluated in combination with specifications, sources and regional policies.H···【more】
Article source：Captain MedicineRelease date：2025-04-11Recommended：299
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6372024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：912026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4162025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4372025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4212025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4772025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3862025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
